Literature DB >> 7809087

Somatic mutation of immunoglobulin lambda chains: a segment of the major intron hypermutates as much as the complementarity-determining regions.

A González-Fernández1, S K Gupta, R Pannell, M S Neuberger, C Milstein.   

Abstract

The rate and nature of hypermutation of immunoglobulin genes are of prime importance in the affinity maturation of antibodies. Although a considerable body of information has been gathered for kappa light chains, there is much less data for lambda chains. We have derived a large data base of somatic mutants of mouse lambda 1 light chains from Peyer's patches germinal center B cells. The endogenous lambda 1 genes mutate at a rate comparable to that previously found for a kappa transgene (V kappa ox1). There are intrinsic hot spots of mutation common to both in-frame and out-of-frame rearrangements; these hot spots cluster in hypermutating domains. In contrast to the pattern seen for V kappa Ox1, the hot spot clusters are found not only in complementarity-determining region (CDR)1 but also in CDR2 and CDR3; mutations also cluster in the joining/constant region intron. The differences between the pattern of mutations in V kappa Ox1 and lambda 1 light chains are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809087      PMCID: PMC45489          DOI: 10.1073/pnas.91.26.12614

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Molecular characterization of single memory B cells.

Authors:  M G McHeyzer-Williams; G J Nossal; P A Lalor
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

2.  Mutation and selection during the secondary response to 2-phenyloxazolone.

Authors:  C Rada; S K Gupta; E Gherardi; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response.

Authors:  M Reth; G J Hämmerling; K Rajewsky
Journal:  Eur J Immunol       Date:  1978-06       Impact factor: 5.532

4.  Molecular events during the onset and maturation of the antibody response.

Authors:  C Milstein; J Even; C Berek
Journal:  Biochem Soc Symp       Date:  1986

Review 5.  Mutation drift and repertoire shift in the maturation of the immune response.

Authors:  C Berek; C Milstein
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

6.  Patterns of somatic mutations in immunoglobulin variable genes.

Authors:  G B Golding; P J Gearhart; B W Glickman
Journal:  Genetics       Date:  1987-01       Impact factor: 4.562

7.  Peculiarities of immunoglobulin gene structures as a basis for somatic mutation emergence.

Authors:  N A Kolchanov; V V Solovyov; I B Rogozin
Journal:  FEBS Lett       Date:  1987-04-06       Impact factor: 4.124

Review 8.  Lambda chains and genes in inbred mice.

Authors:  H N Eisen; E B Reilly
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

9.  Analysis of individual immunoglobulin lambda light chain genes amplified from single cells is inconsistent with variable region gene conversion in germinal-center B cell somatic mutation.

Authors:  J E Ford; M G McHeyzer-Williams; M R Lieber
Journal:  Eur J Immunol       Date:  1994-08       Impact factor: 5.532

10.  Clonal recruitment and somatic mutation in the generation of immunological memory to the hapten NP.

Authors:  A Cumano; K Rajewsky
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  18 in total

1.  Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation.

Authors:  H Zan; A Cerutti; P Dramitinos; A Schaffer; Z Li; P Casali
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

2.  The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially.

Authors:  C Rada; C Milstein
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

3.  DNA breaks in hypermutating immunoglobulin genes: evidence for a break-and-repair pathway of somatic hypermutation.

Authors:  Q Kong; N Maizels
Journal:  Genetics       Date:  2001-05       Impact factor: 4.562

Review 4.  Does DNA repair occur during somatic hypermutation?

Authors:  Huseyin Saribasak; Patricia J Gearhart
Journal:  Semin Immunol       Date:  2012-06-22       Impact factor: 11.130

5.  JH6 downstream intronic sequence is dispensable for RNA polymerase II accumulation and somatic hypermutation of the variable gene in Ramos cells.

Authors:  Diana P Castiblanco; Darrell D Norton; Robert W Maul; Patricia J Gearhart
Journal:  Mol Immunol       Date:  2018-04-04       Impact factor: 4.407

6.  Both DNA strands of antibody genes are hypermutation targets.

Authors:  C Milstein; M S Neuberger; R Staden
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

7.  Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation.

Authors:  B Goyenechea; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  DNA polymerase mu (Pol mu), homologous to TdT, could act as a DNA mutator in eukaryotic cells.

Authors:  O Domínguez; J F Ruiz; T Laín de Lera; M García-Díaz; M A González; T Kirchhoff; C Martínez-A; A Bernad; L Blanco
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

Review 9.  What Targets Somatic Hypermutation to the Immunoglobulin Loci?

Authors:  Justin M H Heltzel; Patricia J Gearhart
Journal:  Viral Immunol       Date:  2019-11-26       Impact factor: 2.257

10.  Somatic hypermutation of the new antigen receptor gene (NAR) in the nurse shark does not generate the repertoire: possible role in antigen-driven reactions in the absence of germinal centers.

Authors:  M Diaz; A S Greenberg; M F Flajnik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.